Mounjaro is a dual GLP-1/GIP receptor agonist whilst Ozempic is a GLP-1 receptor agonist, both administered as weekly subcutaneous injections
By fiscal year 2023, 67,000 Ohioans were using these drugs, doubling the number from two years prior, with taxpayer costs reaching $356 million
The official description says the liquid should be clear and colorless to a little bit yellow
So your point about cancer, the way we try to diagnose cancer today is secondary prevention
Their effectiveness depends not just on affordability, but on sustained, guided use as part of a broader strategy that includes diet, lifestyle and regular medical care.
This is why anyone considering, using or prescribing GLP-1 medication should pair it with: Progressive resistance training (Jensen 2024) High-quality protein at each meal (Phillips & Paddon-Jones 2023) Lower-glycaemic, minimally processed foods (Ludwig & Ebbeling 2022) Adequate sleep and stress management (Walker 2020) These behaviours protect muscle, bone, metabolic rate and long-term health things the medication cannot do on its own